Build where demand is structurally guaranteed
1,405 acres of investment-ready pharmaceutical and medical device infrastructure serving East and Southern Africa.
Why Tanzania, Why Now
$1B+ Market Today
Tanzania's pharmaceutical market already exceeds one billion dollars a year.
$491M Guaranteed Offtake
MSD procures every year and prefers qualifying local manufacturers by 15%.
780M+ Regional Consumers
One plant reaches the combined EAC and SADC markets.
ML-3 TMDA Classification
A WHO Maturity Level 3 regulator with a 60-day fast-track for the zone.
1,405 Acres
Two investment-ready sites: Mloganzila (405 ac) and Bagamoyo (1,000 ac).
One zone, two regulated manufacturing sectors.
Pharmaceuticals
- Essential generics with MSD framework demand
- API and excipients with zero EAC competition
- Vaccines and biologics as a national priority
Medical Devices
- Over 90% of devices and consumables imported today
- Purpose-built 50-acre devices zone with cleanroom plots
- Diagnostics and IVDs at roughly 99% import dependence
Convert browsing into shortlisting.
Two Strategic Locations. One Vision.
Mloganzila
405 acres · Dar es Salaam
Brownfield-ready site beside the national referral hospital. Phase 1 allocations are open now through the PIAT Green-Lane.
View ZoneBagamoyo
1,000 acres · Coastal greenfield
Reserved for strategic investors of USD 50M and above, with deep-water port access and masterplanning partnership.
View ZoneA Ministry of Health initiative
Build Manufacturing Base
Two purpose-built sites with pharma-grade utilities.
De-risk Investment
Incentives, fast-track regulation, and a single PIAT contact.
Anchor Demand
MSD's USD 491M annual procurement with local preference.
Open Regional Markets
EAC and SADC reach from one Tanzanian plant.
Ready to establish your presence in East Africa?
PIAT responds to every expression of interest within five working days.